AzTrials
AzTrials

Protein-energy; ImbalanceNCT05998603

Pre-sleep Protein Supplementation and Load Carriage Recovery in British Army Recruits

A study testing High protein intake and Moderate protein intake in people with Protein-energy; Imbalance and Muscle Soreness, run by Anglia Ruskin University at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Load carriage is a common military activity and has been shown to induce acute exercise-induced muscle damage (EIMD) and impair muscle function. Protein supplementation can accelerate muscle recovery by attenuating EIMD and muscle function loss. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Protein-energy; Imbalance, Muscle Soreness
What is being tested?
High protein intake and Moderate protein intake
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
122 participants
Where
1 siteUnited Kingdom
Study dates
1 May 2021to 31 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Enrolled into British Army basic training
  • Medically fit to train and complete the load carriage test

Who cannot join

  • Not taking any other nutritional supplement
  • Pregnant

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Anglia Ruskin University

    Cambridge, Cambridgeshire, CB1 1PT

Other trials in United Kingdom

About this study

Official title: Pre-sleep Protein Supplementation Does Not Improve Recovery From Load Carriage in British Army Recruits

Load carriage is a common military activity and has been shown to induce acute exercise-induced muscle damage (EIMD) and impair muscle function. Protein supplementation can accelerate muscle recovery by attenuating EIMD and muscle function loss. This study investigated the impact of an additional daily bolus of protein prior to sleep throughout training on acute muscle recovery following a load carriage test in British Army recruits. Muscle function (maximal jump height), perceived muscle soreness and urinary markers of muscle damage were assessed before (PRE), immediately post (POST), 24-hours post (24h-POST) and 40-hours post (40h-POST) a load carriage test.

Read the detailed description

British Army basic training (BT) is physically demanding with new recruits completing multiple bouts of physical activity each day with limited recovery. Load carriage is one of the most physically demanding BT activities and has been shown to induce acute exercise-induced muscle damage (EIMD) and impair muscle function. Protein supplementation can accelerate muscle recovery by attenuating EIMD and muscle function loss. This study investigated the impact of an additional daily bolus of protein prior to sleep throughout training on acute muscle recovery following a load carriage test in United Kingdom (UK) British Army recruits. A mixed group (men/women) over over 120 new recruits were randomised to dietary control (CON), carbohydrate placebo (PLA), moderate (20g; MOD) or high (60g; HIGH) protein supplementation. Muscle function (maximal jump height), perceived muscle soreness and urinary markers of muscle damage were assessed before (PRE), immediately post (POST), 24-hours post (24h-POST) and 40-hours post (40h-POST) a load carriage test. The underlying aim of this study was to assess whether additional protein intake could attenuate aspects of muscle damage from an acute load carriage test including muscle function, muscle soreness and biomarkers of muscle damage during short term recovery.

Being tested
High protein intake, Moderate protein intake, Carbohydrate maltodextrin placebo, Control no supplementation
Medical subject headings
Myalgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High protein intakeDietary supplement

    The participants received a 60g whey protein bolus each evening prior to sleep pre and post a military load carriage test.

  • Moderate protein intakeDietary supplement

    The participants received a 20g whey protein bolus each evening prior to sleep pre and post a military load carriage test.

  • Carbohydrate maltodextrin placeboDietary supplement

    The participants received an isocaloric carbohydrate bolus each evening prior to sleep pre and post a military load carriage test.

  • Control no supplementationOther

    Control group, no supplementation, only basic training

Study groups in NCT05998603
Study groupRoleWhat they receive
High protein intake supplementationExperimentalA 60g daily dose of whey protein supplementation
Receives: Dietary Supplement: High protein intake
Moderate protein intake supplementationExperimentalA 20g dose of whey protein supplementation
Receives: Dietary Supplement: Moderate protein intake
Carbohydrate placeboPlacebo comparatorAn isocaloic maltodextrin carbohydrate placebo
Receives: Dietary Supplement: Carbohydrate maltodextrin placebo
Control group, no supplementationOtherControl group, not taking any supplementation, only completing basic training activities
Receives: Other: Control no supplementation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in lower body muscle function

    The change in maximal vertical jump height in participants before and after the load carriage test

    Measured: 40-hours

Secondary outcomes (3)
  1. The change in urinary myoglobin

    The relative change in concentration of urinary myoglobin (ng/ml) in participants before and after the load carriage test

    Measured: 40-hours

  2. The change in urinary 3-methylhistidine

    The relative change in concentration of urinary 3-methylhistidine (nmol/ml) in participants before and after the load carriage test

    Measured: 40-hours

  3. The change in perceived muscle soreness

    The relative change in perceived muscle soreness assessed via visual analogue scale. The participants were asked to record their perceived muscle soreness using a 0-10 Likert scale (e.g., 0=no pain, 10=severe pain that limits the ability to move).

    Measured: 40-hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2023
  2. Study start1 May 2021
  3. Primary completion31 May 2022
  4. Study completion31 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
122 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05998603
Sponsor's protocol ID
1076/MODREC/20B
Status last verified
Feb 2024
First submitted
3 Aug 2023
Last updated
26 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing High protein intake and Moderate protein intake in people with Protein-energy; Imbalance and Muscle Soreness, run by Anglia Ruskin University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in lower body muscle function (time frame: 40-hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2024; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in